Abstract submission is closed.
Introduced last year, we are excited to announce 2nd Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2022. Submitters can apply for this award and the Scientific Program Committee will select 3 winners. Winners will receive €10 000 and the opportunity to present their work on Day 1.
We would like to encourage especially young investigators to submit their abstracts for a chance to be featured in the main program! For more information, see the Abstract Awards page.
Select the topic that best fits your abstract from the list below:
- Pre-clinical data
- Clinical data – academic
- Clinical data – biotech/industry
- Patient Advocacy data
For any questions regarding the abstract submission process, please contact firstname.lastname@example.org.
The abstracts will be reviewed and allocated by the Scientific Program Committee. Submitting authors will be informed about the allocation by the 17th of December 2021.
Please note that the submission of an abstract constitutes a formal commitment by the author to attend the meeting (if the abstract is accepted) and, if required, present the abstract as an oral presentation or ePoster in the session and the time assigned by the Scientific Program Committee. Presenting authors of accepted abstracts will be allowed to register for the early fee, for which the details will be shared in the acceptance letter. All other authors wishing to attend the meeting should register before the 9th of January 2022 to make use of the early registration fee.